Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
18
2023
FDA’s Proposed Rule on LDT Regulation and the Debate over Agency Deference Sheppard, Mullin, Richter & Hampton LLP
Oct
18
2023
Behavioral Health Law Ledger | October 2023 Greenberg Traurig, LLP
Oct
18
2023
California Attorney General Issues Enforcement Advisory Letter to Warn Companies of Responsibility to Disclose Presence of PFAS Bergeson & Campbell, P.C.
Oct
18
2023
DOJ's Consumer Protection Branch Continues Civil Enforcement Against Pharmacies, Pharmacists for Opioid Dispensing Barnes & Thornburg LLP
Oct
18
2023
OECD Tour de Table Includes Information on U.S. Developments on Human Health and Environmental Safety of Nanomaterials Bergeson & Campbell, P.C.
Oct
18
2023
FDA Issues New Enforcement Policy for Face Masks and Barrier Face Coverings ArentFox Schiff LLP
Oct
18
2023
Califf Provides Update on Front-of-Package Labeling Keller and Heckman LLP
Oct
17
2023
CPSC Signals its Regulatory Interest in PFAS Foley & Lardner LLP
Oct
17
2023
Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule Sheppard, Mullin, Richter & Hampton LLP
Oct
17
2023
Revamping Cosmetics Safety and Regulation: Updates from FDA on Regulatory Changes under MOCRA. Squire Patton Boggs (US) LLP
Oct
17
2023
United Cannabis Corporation v. Pure Hemp Collective Inc. Sheppard, Mullin, Richter & Hampton LLP
Oct
17
2023
Pharmacy Benefit Manager Reform: What’s on the Horizon? McDermott Will & Emery
Oct
17
2023
The Roundabout: AMCC Litigation and Licensing Update Bradley Arant Boult Cummings LLP
Oct
17
2023
Public Meeting on Strategies to Reduce Added Sugar Consumption Set for November Keller and Heckman LLP
Oct
17
2023
Is Medical Cannabis an Effective Treatment for Autism? A Recent US DHHS Recommendation Renews Hope for Much Needed Research Womble Bond Dickinson (US) LLP
Oct
17
2023
Recent Federal Developments, October 2023 Bergeson & Campbell, P.C.
Oct
16
2023
The Fine Print: Avoiding IP Pitfalls in Unlicensed Fonts McDermott Will & Emery
Oct
16
2023
FDA Publishes Updated Prior Notice of Imported Food Guidance Document Keller and Heckman LLP
Oct
16
2023
Rite Aid Chapter 11 Bankruptcy Filing: Just What the Doctor Ordered Stark & Stark
Oct
14
2023
Registration Opens for Nano4Earth Roundtable Discussion on Capture of GHGs Bergeson & Campbell, P.C.
Oct
13
2023
McDermottPlus Check-Up: October 13, 2023 McDermott Will & Emery
Oct
13
2023
Alive and Well: Daubert Challenges Based on an Expert’s Lack of Qualifications Phillips Lytle LLP
Oct
13
2023
Governor Signs Bill Prohibiting Any Grocery Store Purchases Without Prior Written Notice To The Attorney General Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
12
2023
FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors [Podcast] K&L Gates
Oct
12
2023
California’s Transformational Single-Use Packaging EPR Law Moves Toward Implementation Beveridge & Diamond PC
Oct
12
2023
DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 Polsinelli PC
Oct
12
2023
Cell-Cultivated Meat Is Gaining Ground Womble Bond Dickinson (US) LLP
Oct
12
2023
DEA Further Extends Telemedicine Prescribing Flexibilities Dinsmore & Shohl LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins